![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, November 05, 2021 3:44:26 AM
IPO pps is $14.
Thu, November 4, 2021, 11:52 PM.
https://finance.yahoo.com/news/io-biotech-inc-announces-pricing-035200314.html?fr=sycsrp_catchall
Sunstone and Novo Holdings involved.
Recent IOBT News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/11/2024 08:44:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:18:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:14:19 PM
- IO Biotech to Present at Jefferies Global Healthcare Conference • GlobeNewswire Inc. • 05/23/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 12:30:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2024 12:13:53 PM
- IO Biotech Reports First Quarter 2024 Financial Results and Provides Business Highlights • GlobeNewswire Inc. • 05/14/2024 11:55:00 AM
- IO Biotech Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting • GlobeNewswire Inc. • 04/24/2024 08:30:00 PM
- IO Biotech Expands Senior Leadership Team to Progress Commercialization Readiness • GlobeNewswire Inc. • 04/15/2024 12:30:00 PM
- IO Biotech Presents New Data at AACR 2024 Further Supporting Dual Mechanism of Action of Lead Cancer Vaccine, IO102-IO103 • GlobeNewswire Inc. • 04/09/2024 04:00:00 PM
- IO Biotech Appoints Faiçal Miyara, Ph.D., as Chief Business Officer • GlobeNewswire Inc. • 04/05/2024 12:30:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/11/2024 08:56:44 PM
- IO Biotech Announces Acceptance of Abstract to be Presented at the 2024 American Association for Cancer Research (AACR) Annual Meeting • GlobeNewswire Inc. • 03/06/2024 09:11:01 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/05/2024 10:17:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 09:46:56 PM
- IO Biotech Announces 2023 Fourth-Quarter and Year-End Results • GlobeNewswire Inc. • 03/05/2024 09:40:01 PM
- IO Biotech to Present at 44th Annual Cowen Health Care Conference • GlobeNewswire Inc. • 02/26/2024 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 01:11:55 PM
- IO Biotech Announces First Patient Dosed in Phase 2 Neoadjuvant/Adjuvant Solid Tumor Basket Trial • GlobeNewswire Inc. • 12/21/2023 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/24/2023 10:37:11 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:15:37 PM
- IO Biotech Announces 2023 Third Quarter Results • GlobeNewswire Inc. • 11/13/2023 01:12:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 01:10:53 PM
- IO Biotech Appoints Helen Collins, MD, to its Board of Directors • GlobeNewswire Inc. • 11/13/2023 01:00:00 PM
- IO Biotech Completes Enrollment of 380 Patients in Pivotal Phase 3 Trial in Advanced Melanoma • GlobeNewswire Inc. • 11/10/2023 01:00:00 PM
FEATURED Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM
HealthLynked Expands Telemedicine Nationwide • HLYK • Jul 17, 2024 8:00 AM
Peer To Peer Network aka Mobicard™ Launches AI Investor Chatbot Boosting Engagement & Lead Generation on Ihub • PTOP • Jul 15, 2024 8:30 AM
Greenlite Ventures Announces AI Integration into No Limit Platforms • GRNL • Jul 15, 2024 8:00 AM